New Delhi: The Delhi High Court today directedthe Drug Controller General of India to process the licenceapplication of Cipla for production and sale of genericversion of global pharma major Bayer Corporation`s liver andkidney cancer drug `Nexavar`.
Pune blast: ATS tracking online chats of IM terrorists
Devotees throng Mathura on the occassion of Guru Purnima
Shirdi Sai Baba is not God or Guru: Shankaracharya
UPSC aspirants protest outside Rajnath Singh`s residence